Assessment of Non-cultured Autologous Epidermal Cell Grafting Resuspended in Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism Lesions: A Randomized Clinical Trial
DOI:
https://doi.org/10.2340/00015555-3870Keywords:
non-cultured epidermal cells, autologous grafting, repigmentation, leukoderma, vitiligo, piebaldismAbstract
The aim of this study was to assess the efficacy of non-cultured autologous epidermal cell grafting resuspended in hyaluronic acid, performed using a ready-to-use kit, compared with hyaluronic acid alone (neutral comparator) for repigmenting vitiligo and piebaldism lesions at 6 months. Two identified paired lesions per patient were randomized to be treated by either device. Devices with a ready-to-use kit were prepared by separate health professionals, to maintain blinding. A skin biopsy was digested using trypsin, and cells resuspended in hyaluronic acid solution. Among 38 patients screened, 36 (94.7%) patients, corresponding to 72 lesions, were analysed. For difficult-to-treat lesions, defined as those located on the wrist, elbow, and hands (n = 30), no repigmentation ≥ 50% was observed. For all other locations (n = 42), the success rate was significantly higher (p = 0.021) in the ready-to-use kit group (47.6% vs 9.5%) at 6 months and was maintained until 12 months. In conclusion, a single application of non-cultured epidermal cellular grafting using a ready-to-use kit was efficient at 6 months and at 1-year follow-up.
Downloads
References
Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes 2003; 1: 58.
Elbuluk N, Ezzedine K. Quality of life, burden of disease, co-morbidities, and systemic effects in vitiligo patients. Dermatol Clin 2017; 35: 117–128.
Passeron T. Leucodermies. EMC – Dermatologie 2016; [Article 98-585-A-10]: 1–11.
Taïeb A, Picardo M. Clinical practice. Vitiligo. N Engl J Med 2009; 360: 160–169.
Debbarh FZ, Mernissi FZ. Piebaldisme: une génodermatose rare. Pan Afr Med J 2017; 27: 221.
Borderé AC, Lambert J, van Geel N. Current and emerging therapy for the management of vitiligo. Clin Cosmet Investig Dermatol 2009; 2: 15–25.
Gauthier Y, Surleve-Bazeille JE. Autologous grafting with noncultured melanocytes: a simplified method for treatment of depigmented lesions. J Am Acad Dermatol 1992; 26: 191–194.
van Geel N, Ongenae K, Mil M de, Haeghen YV, Vervaet C, Naeyaert JM. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo. Arch Dermatol 2004; 140: 1203–1208.
Laboratoires Genevrier. Available from: https://www.youtube.com/watch?v=OzjjVFPHWQU.
Pell G. Use and misuse of Likert scales. Med Educ 2005; 39: 970.
Mulekar SV. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation. Int J Dermatol 2005; 44: 841–845.
Mulekar SV, Al Issa A, Al Eisa A. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting. Dermatol Surg 2009; 35: 66–71.
Razmi T M, Kumar R, Rani S, Kumaran SM, Tanwar S, Parsad D. Combination of follicular and epidermal cell suspension as a novel surgical approach in difficult-to-treat vitiligo: a randomized clinical trial. JAMA Dermatol March 2018; 154: 301–308.
Cook JA, Bruckner T, MacLennan GS, Seiler CM. Clustering in surgical trials – database of intracluster correlations. Trials 2012; 13: 2.
Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, et al. Guideline for the diagnosis and management of vitiligo. Br J Dermatol 2008; 159: 1051–1076.
Yones SS, Palmer RA, Garibaldinos TM, Hawk JLM. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs narrowband-UV-B therapy. Arch Dermatol 2007; 143: 578–584.
Njoo MD, Westerhof W, Bos JD, Bossuyt PM. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol 1998; 134: 1543–1549.
Passeron T, Ortonne JP. Use of the 308-nm excimer laser for psoriasis and vitiligo: clinics in dermatology. Clin Dermatol 2006; 24: 33–42.
Ezzedine K, Whitton M, Pinart M. Interventions for vitiligo. JAMA 2016; 316: 1708–1709.
Guerra L, Primavera G, Raskovic D, Pellegrini G, Golisano O, Bondanza S, et al. Permanent repigmentation of piebaldism by erbium:YAG laser and autologous cultured epidermis. Br J Dermatol 2004; 150: 715–721.
Published
How to Cite
License
Copyright (c) 2021 Antoine Bertolotti, Giovanni Leone, Alain Taïeb, Emilie Soriano, Michel Pascal, Hervé Maillard, Nanja van Geel
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
